Promoter Methylation and Lung Cancer
Author Information
Author(s): Ji Meiju, Zhang Yong, Shi Bingyin, Hou Peng
Primary Institution: The First Affiliated Hospital of Xi'an Jiaotong University College of Medicine
Hypothesis
Is there an association between promoter methylation and histologic type in non-small cell lung cancer (NSCLC)?
Conclusion
Promoter methylation is frequently observed in NSCLC and is associated with histologic type and increased risk of pleural indentation.
Supporting Evidence
- Promoter methylation was found in 100% of the samples analyzed.
- High sensitivity for detecting NSCLC was observed across the six genes studied.
- Promoter methylation was more frequent in squamous cell carcinomas compared to adenocarcinomas.
- Significant associations were found between methylation levels and clinicopathologic characteristics.
Takeaway
This study found that certain genes are often changed in lung cancer, which can help doctors tell if someone has the disease and how serious it is.
Methodology
Quantitative methylation-specific PCR (Q-MSP) was used to analyze promoter methylation in tumor samples.
Potential Biases
Potential bias due to the selection of samples and the retrospective nature of the study.
Limitations
The study may not account for all potential confounding factors related to smoking and other risk factors.
Participant Demographics
{"gender":{"male":66,"female":30},"mean_age":58.9,"smoking_history":{"none":30,"1-39":35,"40_or_more":31}}
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI = 1.05-6.60
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website